Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Anecdotes abound about “Ozempic babies”—when women wound up with unplanned pregnancies while taking both birth-control and ...

The European Medicines Agency has identified a rare eye condition risk linked to Novo Nordisk’s semaglutide drugs.

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Women taking popular weight-loss drugs have been urged to use effective contraception while taking the medication amid ...

Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to ...

The rising trend of sweet-smelling gourmand fragrances coincides with anecdotal reports from GLP-1 weight-loss drug users ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...